Audent Global Asset Management LLC Lowers Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Audent Global Asset Management LLC trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 6.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,644 shares of the financial services provider’s stock after selling 585 shares during the quarter. iShares Biotechnology ETF accounts for 2.1% of Audent Global Asset Management LLC’s holdings, making the stock its 18th largest holding. Audent Global Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $1,259,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth $29,000. Highline Wealth Partners LLC bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth $30,000. Bbjs Financial Advisors LLC bought a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth $31,000. Ashton Thomas Securities LLC bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth $36,000. Finally, Voisard Asset Management Group Inc. bought a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth $59,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.0 %

Shares of NASDAQ:IBB opened at $141.55 on Monday. The business’s 50-day moving average is $142.71 and its 200 day moving average is $142.06. iShares Biotechnology ETF has a 1 year low of $119.95 and a 1 year high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.